Company Filing History:
Years Active: 2014-2015
Title: Thomas Skinner: Innovator in Neural Disease Treatment
Introduction
Thomas Skinner is a notable inventor based in Halifax, Canada. He has made significant contributions to the field of neural disease treatment, holding 2 patents that focus on innovative methods for addressing neurodegenerative conditions. His work is crucial in advancing medical science and improving patient outcomes.
Latest Patents
Skinner's latest patents involve the treatment of neural diseases or conditions. These patents describe compounds, methods, uses, compositions, kits, and packages for the prevention and/or treatment of neural injury or neurodegenerative diseases. The innovations are based on the use of a retinoic acid derivative, such as fenretinide, along with its analogs, derivatives, prodrugs, precursors, and salts.
Career Highlights
Thomas Skinner is affiliated with the Royal Institution for the Advancement of Learning / McGill University. His work at this prestigious institution has allowed him to explore and develop groundbreaking treatments for neural conditions. His research is instrumental in the ongoing fight against neurodegenerative diseases.
Collaborations
Skinner has collaborated with esteemed colleagues, including Danuta Radzioch and Samuel David. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.
Conclusion
Thomas Skinner's contributions to the treatment of neural diseases highlight his role as an innovative inventor in the medical field. His patents and collaborations reflect a commitment to advancing healthcare solutions for neurodegenerative conditions.